With the coronavirus pandemic far from over and scientists' warning of a winter surge, China has formulated a response to small-scale clusters to secure its success in controlling the disease. Applied in Beijing in June, Dalian in July, Qingdao and Kashgar in October, and the current outbreaks in Tianjin, Shanghai and the border city of Manzhouli, mass testing and contact tracing are containing them. Chinese medical workers never give up when confronting the COVID-19 virus. China currently has five vaccines in phase-three clinical trials.
